Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-03-28
DOI
10.1016/j.ajog.2023.03.032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of antiangiogenic factors in the pathogenesis of preeclampsia
- (2022) S. Ananth Karumanchi et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- When to give aspirin to prevent preeclampsia: application of Bayesian decision theory
- (2022) David Wright et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia
- (2022) Pierre-Yves Robillard et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Extracorporeal membrane oxygenation in pregnancy: details on novel therapies and cardiac, preeclampsia, and mood disorder complications
- (2022) Ophelia Yin et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Delivery outcomes after induction of labor among women with hypertensive disorders of pregnancy
- (2022) Miah J. Hagans et al. Journal of Maternal-Fetal & Neonatal Medicine
- Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis
- (2022) Alice Beardmore-Gray et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The etiology of preeclampsia
- (2022) Eunjung Jung et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia
- (2022) Jonathan Lai et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Diagnostic Utility of Serial Circulating Placenta Growth Factor Levels and Uterine Artery Doppler Waveforms to Diagnose Underlying Placental Diseases in Pregnancies at High-Risk of Placental Dysfunction
- (2022) Swati AGRAWAL et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Placental pathology is necessary to understand common pregnancy complications and achieve an improved taxonomy of obstetric disease
- (2022) Raymond W. Redline et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The implications of the Fetal Medicine Foundation 35-36 week preeclampsia prediction competing risk model on timing of birth
- (2022) Peter von Dadelszen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Low-dose aspirin for the prevention of superimposed pre-eclampsia in women with chronic hypertension: a systematic review and meta-analysis.
- (2022) Dr Eleanor M F Richards et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology
- (2022) Roberto Romero et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A novel approach to joint prediction of preeclampsia and delivery timing using semicompeting risks
- (2022) Harrison T. Reeder et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Molecular subclasses of preeclampsia characterized by a longitudinal maternal proteomics study: distinct biomarkers, disease pathways and options for prevention
- (2022) Nándor Gábor Than et al. JOURNAL OF PERINATAL MEDICINE
- An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array
- (2021) Simcha Yagel et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial
- (2021) Anna Peguero et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Competing risks model for prediction of preeclampsia
- (2021) David Wright et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness
- (2021) James M. Roberts et al. HYPERTENSION
- Stratification of pregnancy care based on risk of pre‐eclampsia derived from biophysical and biochemical markers at 19–24 weeks' gestation
- (2021) M. Litwinska et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Two physiological phenotypes in preeclampsia: Does it really exist?
- (2021) Nivedita Jha et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- RESPONSE TO Drs Jha and Jha
- (2021) Christoph Lees et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Preeclampsia has 2 phenotypes which require different treatment strategies
- (2021) Giulia Masini et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia
- (2021) Moritz Döbert et al. CIRCULATION
- A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia
- (2021) Liona C. Poon et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Reply: Timing of pravastatin initiation for preeclampsia prevention
- (2021) Devin D. Smith et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia
- (2021) Ana Sofia Cerdeira et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Statins to prevent or treat preeclampsia: sometimes it is too late
- (2021) Liliana S. Voto et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia
- (2021) Maged M. Costantine et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice
- (2021) Laura A Magee et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- A new model for screening for early-onset preeclampsia
- (2020) Bernat Serra et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Prediction of preterm pre‐eclampsia at midpregnancy using a multivariable screening algorithm
- (2020) Carin Black et al. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
- Cardiovascular events following pregnancies complicated by preeclampsia with emphasis on the comparison between early and late onset forms: a systematic review and meta‐analysis
- (2020) A. Dall'Asta et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- First trimester preeclampsia screening and prediction
- (2020) Piya Chaemsaithong et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: The Great Obstetrical Syndromes (GOS) cohort study
- (2020) Amélie BOUTIN et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia
- (2020) Mahsa Matin et al. HYPERTENSION
- The role of statins in the prevention of preeclampsia
- (2020) Devin D. Smith et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia
- (2020) Stephen Tong et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia
- (2020) Anne Cathrine Staff et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The diagnostic value of angiogenic / anti-angiogenic factors in differential diagnosis of preeclampsia
- (2020) Stefan Verlohren et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Prevention of preeclampsia with aspirin
- (2020) Daniel L. Rolnik et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- IMBALANCES IN CIRCULATING ANGIOGENIC FACTORS IN THE PATHOPHYSIOLOGY OF PREECLAMPSIA AND RELATED DISORDERS
- (2020) Sarosh Rana et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome
- (2020) Richard M. Burwick et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- One Step Closer to a Cure for Preeclampsia?
- (2020) Ana Sofia Cerdeira et al. HYPERTENSION
- Ophthalmic artery Doppler in combination with other biomarkers in the prediction of pre‐eclampsia at 35–37 weeks’ gestation
- (2020) M. Sarno et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia
- (2020) Sean Lim et al. OBSTETRICS AND GYNECOLOGY
- Maternal cardiac function at 19–23 weeks’ gestation in the prediction of pre‐eclampsia
- (2020) E. Gibbone et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Performance of soluble fms-like tyrosine kinase-1–to–placental growth factor ratio of ≥85 for ruling in preeclampsia within 4 weeks
- (2020) Ana Sofia Cerdeira et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Pre-eclampsia: pathogenesis, novel diagnostics and therapies
- (2019) Elizabeth A. Phipps et al. Nature Reviews Nephrology
- Prediction of imminent preeclampsia at 35–37 weeks gestation
- (2019) Anca Ciobanu et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Preeclampsia: the role of persistent endothelial cells in uteroplacental arteries
- (2019) Ivo Brosens et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Aspirin delays the development of preeclampsia
- (2019) David Wright et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial
- (2019) Eva F. Zwertbroek et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia
- (2019) Laura Trapiella-Alfonso et al. HYPERTENSION
- The International Federation of Gynecology and Obstetrics ( FIGO ) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention
- (2019) Liona C. Poon et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Placental Bed Research: 1. The Placental Bed. From Spiral Arteries Remodeling to the Great Obstetrical Syndromes
- (2019) Ivo Brosens et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Placental bed research: 2. Functional and immunological investigations of the placental bed
- (2019) Lynda K. Harris et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia?
- (2019) Piya Chaemsaithong et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
- (2019) John R. Barton et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
- (2019) Lucy C Chappell et al. LANCET
- From first‐trimester screening to risk stratification of evolving pre‐eclampsia in the second and third trimesters of pregnancy: a comprehensive approach
- (2019) Liona C. Poon et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- FIRST TRIMESTER SERUM ANGIOGENIC AND ANTI-ANGIOGENIC FACTORS IN WOMEN WITH CHRONIC HYPERTENSION FOR THE PREDICTION OF PREECLAMPSIA
- (2019) Diane Nzelu et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- THE COMPETING RISK APPROACH FOR PREDICTION OF PREECLAMPSIA
- (2019) David Wright et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Complement Activation and Thrombotic Microangiopathies
- (2019) Marta Palomo et al. Clinical Journal of the American Society of Nephrology
- Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women
- (2019) Swati Agrawal et al. HYPERTENSION
- Increased BMI has a linear association with late-onset preeclampsia: A population-based study
- (2019) Pierre-Yves Robillard et al. PLoS One
- Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population
- (2019) Piya Chaemsaithong et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Early and late preeclampsia are characterized by high cardiac output, but in the presence of fetal growth restriction, cardiac output is low: insights from a prospective study
- (2018) Jasmine Tay et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies
- (2018) Matthew D. F. McInnes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases
- (2018) Xun Li et al. Journal of Clinical Hypertension
- Screening for pre-eclampsia at 35-37 weeks’ gestation
- (2018) Anca Panaitescu et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation
- (2018) M. Litwinska et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation
- (2018) M. Y. Tan et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy
- (2018) C. Birdir et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study
- (2018) I. Herraiz et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
- (2018) Vera Regitz-Zagrosek et al. EUROPEAN HEART JOURNAL
- Predictive performance of the competing risk model in screening for preeclampsia
- (2018) David Wright et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Two-stage screening for preterm preeclampsia at 11-13 weeks’ gestation
- (2018) Alan Wright et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The clinical heterogeneity of preeclampsia is related to both placental gene expression and placental histopathology
- (2018) Samantha J. Benton et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of PregnancyNovelty and Significance
- (2017) U. Vivian Ukah et al. HYPERTENSION
- Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of PreeclampsiaNovelty and Significance
- (2017) Swati Agrawal et al. HYPERTENSION
- Placental growth factor and pre-eclampsia
- (2017) K Chau et al. JOURNAL OF HUMAN HYPERTENSION
- Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin
- (2017) Kate Navaratnam et al. Journal of Maternal-Fetal & Neonatal Medicine
- Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
- (2017) Daniel L. Rolnik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation
- (2017) A. M. Panaitescu et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF
- (2017) M. Y. Tan et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation
- (2017) M. Litwinska et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks’ gestation
- (2016) Andreas Tsiakkas et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study
- (2016) Steven J. Korzeniewski et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19–24 weeks’ gestation
- (2016) Dahiana M. Gallo et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial
- (2016) Maged M. Costantine et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Italian Advisory Board: sFlt-1/PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic and clinical management
- (2016) Daniela Di Martino et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort
- (2016) Louise Bjørkholt Andersen et al. HYPERTENSION IN PREGNANCY
- Pravastatin for the prevention of adverse pregnancy outcome: preeclampsia and more?
- (2016) Tinnakorn Chaiworapongsa et al. Journal of Maternal-Fetal & Neonatal Medicine
- Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation
- (2016) S. Andrietti et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Pravastatin for the Prevention of Preeclampsia in High-Risk Pregnant Women
- (2016) Maged M. Costantine et al. OBSTETRICS AND GYNECOLOGY
- Why is placentation abnormal in preeclampsia?
- (2015) Susan J. Fisher AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies
- (2015) Yuxiu Liu et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013)
- (2015) H. Stepan et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia
- (2015) Tinnakorn Chaiworapongsa et al. Journal of Maternal-Fetal & Neonatal Medicine
- Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population
- (2015) Carolin Kienast et al. Journal of Maternal-Fetal & Neonatal Medicine
- Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia
- (2015) R. Thadhani et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome
- (2015) N. Valiño et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Accuracy of angiogenic biomarkers at ⩽20weeks’ gestation in predicting the risk of pre-eclampsia: A WHO multicentre study
- (2015) Mariana Widmer et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation
- (2014) Santiago Garcia-Tizon Larroca et al. FETAL DIAGNOSIS AND THERAPY
- Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation
- (2014) Jonathan Lai et al. FETAL DIAGNOSIS AND THERAPY
- Pre-eclampsia part 1: current understanding of its pathophysiology
- (2014) Tinnakorn Chaiworapongsa et al. Nature Reviews Nephrology
- Prediction of preeclampsia and induced delivery at
- (2014) Johannes Stubert et al. BMC Pregnancy and Childbirth
- Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy
- (2014) Hee Jin Park et al. BMC Pregnancy and Childbirth
- Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia
- (2013) Tinnakorn Chaiworapongsa et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease
- (2013) Sarka Lisonkova et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Systematic Reviews of Diagnostic Test Accuracy
- (2013) Mariska M.G. Leeflang ANNALS OF INTERNAL MEDICINE
- Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population
- (2013) Caroline Diguisto et al. PRENATAL DIAGNOSIS
- Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
- (2012) Sanjib Kumar Ghosh et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study
- (2012) Sanjib Kumar Ghosh et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
- (2012) Ranjit Akolekar et al. FETAL DIAGNOSIS AND THERAPY
- Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia
- (2012) Tinnakorn Chaiworapongsa et al. Journal of Maternal-Fetal & Neonatal Medicine
- Eculizumab for the treatment of preeclampsia/HELLP syndrome
- (2012) R.M. Burwick et al. PLACENTA
- Threshold of Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio for the Imminent Onset of Preeclampsia
- (2011) Akihide Ohkuchi et al. HYPERTENSION
- Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia
- (2011) Giovanna Ogge et al. JOURNAL OF PERINATAL MEDICINE
- Early Prediction of Preeclampsia in High-Risk Women
- (2011) Olfat Gamil Shaker et al. JOURNAL OF WOMENS HEALTH
- Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
- (2010) Robert W. Powers et al. PLoS One
- A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
- (2009) Juan Pedro Kusanovic et al. Journal of Maternal-Fetal & Neonatal Medicine
- Induced labour for pre-eclampsia and gestational hypertension
- (2009) Donna D Johnson LANCET
- Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial
- (2009) Corine M Koopmans et al. LANCET
- Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?
- (2008) Baha M. Sibai et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry
- (2008) Abdalla E. Diab et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
- (2008) Roberto Romero et al. Journal of Maternal-Fetal & Neonatal Medicine
- Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia
- (2008) R. Akolekar et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started